Citadel Advisors - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$13,197,439
-44.5%
4,163,230
-13.1%
0.00%
-40.0%
Q2 2023$23,800,043
+9.6%
4,788,741
+9.0%
0.01%0.0%
Q1 2023$21,709,339
+504.2%
4,394,603
+669.4%
0.01%
+400.0%
Q4 2022$3,592,873
-64.4%
571,204
-38.9%
0.00%
-50.0%
Q3 2022$10,097,000
+747.8%
934,955
+794.2%
0.00%
Q2 2022$1,191,000
-95.1%
104,563
-96.1%
0.00%
-100.0%
Q1 2022$24,276,000
-33.5%
2,664,811
+8.9%
0.01%
-28.6%
Q4 2021$36,518,000
+308.3%
2,447,597
+603.3%
0.01%
+250.0%
Q3 2021$8,944,000
-23.6%
348,009
-22.5%
0.00%0.0%
Q2 2021$11,713,000
+288.5%
449,110
+426.0%
0.00%
Q1 2021$3,015,000
-66.5%
85,387
-76.1%
0.00%
-100.0%
Q4 2020$9,011,000
+162.6%
357,053
+292.4%
0.00%
+100.0%
Q3 2020$3,431,000
-44.3%
90,989
-36.8%
0.00%0.0%
Q2 2020$6,164,000
+236.8%
143,940
+52.8%
0.00%
Q1 2020$1,830,000
-8.5%
94,186
+22.4%
0.00%
-100.0%
Q4 2019$1,999,000
-79.7%
76,946
-78.7%
0.00%
-80.0%
Q3 2019$9,825,000
-20.0%
360,494
-21.2%
0.01%0.0%
Q2 2019$12,278,000
-37.9%
457,277
-33.1%
0.01%
-50.0%
Q1 2019$19,775,000
+89.0%
684,003
+76.1%
0.01%
+100.0%
Q4 2018$10,463,000388,5180.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders